Table 3 Univariate and multivariate analyses of the overall survival of the 161 TNBC patients
Variable | Overall survival | |||
|---|---|---|---|---|
Univariate analysis | Multivariate analysis | |||
HR (95% CI) | P value | HR (95% CI) | P value | |
Age ≤ 40 years old | 1.133 (0.549–2.340) | 0.736 |  |  |
Family history of cancer | 1.572 (0.705–3.505) | 0.269 |  |  |
Menstruating | 1.131 (0.641–1.996) | 0.670 |  |  |
History of other neoplasms | 1.232 (0.299–5.086) | 0.773 |  |  |
Stage III disease | 4.420 (2.496–7.827) | 0.000 | 2.493 (1.276–4.873) | 0.008 |
T3/ T4 | 2.567 (1.391–4.735) | 0.003 | 0.995 (0.436–2.271) | 0.497 |
Lymph node metastasis | 4.440 (2.262–8.713) | 0.000 | 2.543 (1.151–5.620) | 0.021 |
Poor tumor differentiation | 1.547 (0.788–3.040) | 0.205 |  |  |
Vascular invasion | 3.567 (2.002–6.355) | 0.000 | 1.725 (0.841–3.535) | 0.102 |
Distant metastasis | 1.775 (0.899–3.503) | 0.098 |  |  |
Low ANGPTL4 expression | 2.180 (1.232–3.860) | 0.006 | 1.776 (0.998–3.161) | 0.051 |